DRUG FORMULATIONS FOR CANCER TREATMENT
Compounds and pharmaceutical formulations containing these compounds are described. Also described are methods of making and using the compounds. The compounds include nucleobases, nucleobase analogues, or combinations thereof. In one embodiment, a nucleobase analogue is combined with doxorubicin an...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
01.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compounds and pharmaceutical formulations containing these compounds are described. Also described are methods of making and using the compounds. The compounds include nucleobases, nucleobase analogues, or combinations thereof. In one embodiment, a nucleobase analogue is combined with doxorubicin and encapsulated within a liposome for use in inhibiting or preventing the growth of cancer cells. Further described are pharmaceutical compositions containing two or more therapeutically active agents encapsulated within a vesicle, such as a liposome, wherein the molar ratio of the agents provides a synergistic therapeutic effect.
La présente invention concerne des composés et des formulations pharmaceutiques contenant ces composés. L'invention porte en outre sur des procédés de production et d'utilisation de ces composés. Les composés incluent des nucléobases, des analogues de nucléobases, ou leurs combinaisons. Dans un mode de réalisation, un analogue de nucléobase est combiné à la doxorubicine et encapsulé dans un liposome pour inhiber ou empêcher la croissance de cellules cancéreuses. L'invention concerne en outre des compositions pharmaceutiques contenant au moins deux agents actifs au plan thérapeutique encapsulés dans une vésicule, telle qu'un liposome, le rapport molaire des agents fournissant un effet thérapeutique synergique. |
---|---|
Bibliography: | Application Number: WO2016US63668 |